Ketamine for Opioid Use Disorder
Phase 2
50
about 3.6 years
18–65
1 site in MD
About this study
Researchers are testing if ketamine helps reduce opioid cravings in adults starting methadone treatment. The trial also investigates whether low doses of ketamine improve symptoms like depression and pain, and whether it leads to better treatment outcomes compared to a very low dose.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Treatment with Ketamine
- 2.Take Treatment with Very Low Dose Ketamine
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
ketamine (NMDA receptor antagonist; induces dissociative anesthesia and analgesia), anesthetic (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)
Secondary: Chronic pain ratings, Insomnia Symptoms, Severity of depression symptoms, Sleep quality ratings on a Visual Analogue Scale (VAS)
Psychiatry / Mental Health